Prevymis (letermovir) - Merck (MSD)
Deciphering Letermovir's Mode of Action and Resistance Mutation Effects. (PubMed, Antiviral Res) - Oct 10, 2025 - "These findings suggest letermovir does not act by directly inhibiting interactions among HCMV terminase subunits. Analysis of resistance-associated mutations provides insight into the molecular basis of HCMV resistance to letermovir and may inform development of novel antiviral strategies targeting the terminase complex." 
Journal • Cytomegalovirus Infection • Infectious Disease • Oncology
http://www.ncbi.nlm.nih.gov/pubmed/41067565
 
C Gourin; C Lefevre; G Ligat; S Alain; S Hantz; T Flores
 
Oct 10, 2025
 
Prev Next